AR046205A1 - Formulacion farmaceutica de licofelona - Google Patents
Formulacion farmaceutica de licofelonaInfo
- Publication number
- AR046205A1 AR046205A1 ARP040103905A ARP040103905A AR046205A1 AR 046205 A1 AR046205 A1 AR 046205A1 AR P040103905 A ARP040103905 A AR P040103905A AR P040103905 A ARP040103905 A AR P040103905A AR 046205 A1 AR046205 A1 AR 046205A1
- Authority
- AR
- Argentina
- Prior art keywords
- water soluble
- pharmaceutical formulation
- copolymers
- soluble polymer
- licofelona
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 229920001577 copolymer Polymers 0.000 abstract 2
- 229920005862 polyol Polymers 0.000 abstract 2
- 150000003077 polyols Chemical class 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 229920003169 water-soluble polymer Polymers 0.000 abstract 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 abstract 1
- UAWXGRJVZSAUSZ-UHFFFAOYSA-N licofelone Chemical compound OC(=O)CC=1N2CC(C)(C)CC2=C(C=2C=CC=CC=2)C=1C1=CC=C(Cl)C=C1 UAWXGRJVZSAUSZ-UHFFFAOYSA-N 0.000 abstract 1
- 229950003488 licofelone Drugs 0.000 abstract 1
- 229920000609 methyl cellulose Polymers 0.000 abstract 1
- 239000001923 methylcellulose Substances 0.000 abstract 1
- 235000010981 methylcellulose Nutrition 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- 229920002451 polyvinyl alcohol Polymers 0.000 abstract 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 150000005846 sugar alcohols Chemical class 0.000 abstract 1
- 229920001567 vinyl ester resin Polymers 0.000 abstract 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Formulación farmacéutica sólida que comprende licofelona o una sal farmacéuticamente aceptable de la misma y por lo menos un polímero soluble en agua seleccionado entre hidroxialquil celulosa, metil celulosa, polivinil pirrolidonas y copolímeros de los mismos, alcoholes polivinílicos, copolímeros hidrolizados o parcialmente hidrolizados de N-vinilpirrolidona y ésteres vinílicos, y/o por lo menos un poliol soluble en agua seleccionado entre polietilen glicoles con un peso molecular que oscila entre 8000 y 20000 y alcoholes de azúcares. La formulación libera con rapidez el ingrediente activo. Uso de un polímero soluble en agua y/o un poliol soluble en agua para producir dicha formulación farmacéutica.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10351035A DE10351035A1 (de) | 2003-10-31 | 2003-10-31 | Pharmazeutische Licofelone-Formulierung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR046205A1 true AR046205A1 (es) | 2005-11-30 |
Family
ID=34485181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040103905A AR046205A1 (es) | 2003-10-31 | 2004-10-27 | Formulacion farmaceutica de licofelona |
Country Status (4)
| Country | Link |
|---|---|
| AR (1) | AR046205A1 (es) |
| DE (1) | DE10351035A1 (es) |
| TW (1) | TW200524592A (es) |
| WO (1) | WO2005041920A2 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109718220A (zh) * | 2017-10-27 | 2019-05-07 | 天津药物研究院有限公司 | Ml-4000包合物胶囊的制备方法 |
| EP3593792A1 (de) | 2018-07-11 | 2020-01-15 | Welding GmbH & Co. KG | Pharmazeutische zusammensetzung umfassend 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-yl-essigsäurecholinsalz |
| WO2023089636A1 (en) * | 2021-11-21 | 2023-05-25 | Aizant Drug Research Solutions Private Limited | Pharmaceutical compositions of licofelone |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11507670A (ja) * | 1995-06-12 | 1999-07-06 | ジー．ディー．サール アンド カンパニー | シクロオキシゲナーゼ−２インヒビターと５−リポキシゲナーゼインヒビターの組合せによる炎症と炎症関連疾患の治療 |
| ATE210461T1 (de) * | 1996-02-13 | 2001-12-15 | Searle & Co | Zusammensetzungen mit immunosuppressiven wirkungen, welche 5-lipoxygenase-inhibitoren und cyclooxygenase-2-inhibitoren enthalten |
| DE10121252A1 (de) * | 2001-04-30 | 2002-11-07 | Christos C Zouboulis | Behandlung der Akne |
| DE60317661T2 (de) * | 2002-05-17 | 2008-10-30 | Merckle Gmbh | Annelierte pyrrol-verbindungen als protonenpumpenhemmer zur behandlung von geschwüren |
-
2003
- 2003-10-31 DE DE10351035A patent/DE10351035A1/de not_active Withdrawn
-
2004
- 2004-10-27 AR ARP040103905A patent/AR046205A1/es unknown
- 2004-10-29 TW TW093133050A patent/TW200524592A/zh unknown
- 2004-10-29 WO PCT/EP2004/012266 patent/WO2005041920A2/de not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005041920A3 (de) | 2005-07-14 |
| WO2005041920A2 (de) | 2005-05-12 |
| DE10351035A1 (de) | 2005-05-25 |
| TW200524592A (en) | 2005-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5261563A1 (es) | Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco | |
| ATE238813T1 (de) | Wirkstoffformulierungen mit verzögerter freisetzung | |
| ITMI20001173A0 (it) | Composizioni farmaceutiche a rilascio prolungato per la somministrazione parenterale di sostanze idrofile biologicamente attiva. | |
| PE20061160A1 (es) | Sistema de administracion de farmacos con retencion gastrica | |
| DE60005819D1 (de) | Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe | |
| NO20011471D0 (no) | Nye orale vedvarende frigivelsesformuleringer | |
| PE20040131A1 (es) | Formulaciones y formas de dosificacion para la administracion controlada de topiramato | |
| AR026968A1 (es) | Una tableta matriz que permite la liberacion prolongada de trimetazidina lluego de su administracion por via oral | |
| CO4940403A1 (es) | Formulaciones de liberacion prolongada de derivados de eri- tromicina | |
| ECSP045102A (es) | Formulación farmacéutica que contiene 3-(3-dimetilamino-1-etil-2-metil-propil)fenol y proporciona una liberación retardada del ingrediente activo | |
| CY1116023T1 (el) | Μορφες φαρμακευτικης δοσολογιας παρατεταμενης απελευθερωσης με περιγραμματα διαλυτοποιησης ελαχιστοποιημενης εξαρτησης απο το ph | |
| AR044131A1 (es) | Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad | |
| AR069552A1 (es) | Formulaciones para el tratamiento de semillas y metodos de uso | |
| PE20061449A1 (es) | Composiciones farmaceuticas comprendiendo imatinib y un retardador de liberacion | |
| NO2013019I1 (no) | Kombinasjon omfattende aliskiren, som den frie basen eller som et farmasøytisk akseptabelt salt derav, og hydroklortiazid eller et farmasøytisk akseptabelt salt derav. | |
| DK1021204T3 (da) | Bioadhæsive præparater og fremgangsmåder til topisk administration af aktive midler | |
| ATE372765T1 (de) | Feste pharmazeutische formulierungen mit telmisartan | |
| AR065073A2 (es) | Una formulacion medicamentosa de sistema de matriz que tiene liberacion controlada de un compuesto activo | |
| AR013117A1 (es) | Una composicion farmaceutica solida en forma de comprimido que comprende un derivado de benzofurano con actividad antiarritmica adaptada para administracion oral | |
| DE60138872D1 (de) | Azetidinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
| CA2385890A1 (en) | Controlled release compositions comprising nimesulide | |
| NO974194D0 (no) | Forbedringer i, eller vedrörende, organiske sammensetninger | |
| AR018862A1 (es) | Formulacion farmaceutica de liberacion prolongada, mejorada para la administracion oral de nefazodona o una sal farmaceuticamente aceptable de la misma;forma de dosificacion oral que la comprende y uso de dicha formulacion para preparar dicha forma de dosificacion | |
| HRP20050195B1 (hr) | Makrolidni spojevi s protuupalnim djelovanjem | |
| ITMI20022292A1 (it) | 9a-azalidi ad attivita' antiinfiammatoria. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |